Sanofi board ousts CEO, aiming for a more 'cooperative' chief

Sanofi ($SNY) CEO Chris Viehbacher is now the French drugmaker's ex-CEO. In a terse statement Wednesday morning, the company's board said it had unanimously voted to fire Viehbacher, who has led the company since 2008. The ouster followed several days of news about conflict between Viehbacher and Sanofi's board. Report

Suggested Articles

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.

Bristol-Myers Squibb and Pfizer's Eliqus has taken the U.S. warfarin alternative market by storm, but can afib screening amp it up even more?